Meilan M. Rutter, MD

Medical Director, Differences/Disorders of Sex Development (DSD) Center

Assistant Director, Pediatric Endocrinology Fellowship Training Program

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-636-4744

Fax 513-636-7486



Pediatric endocrinology, including growth, puberty, thyroid and adrenal disorders; differences / disorders of sex development, or conditions affecting reproductive development; endocrine and bone health in neuromuscular conditions


Differences / disorders of sex development; endocrine issues and bone health associated with Duchenne muscular dystrophy

Meilan Rutter is board-certified in pediatric endocrinology, and has been on the faculty of Cincinnati Children’s Hospital Medical Center and the University of Cincinnati since 2008. She completed her training in the United Kingdom, New Zealand and Cincinnati. She serves as the medical director of the Cincinnati Children’s Differences/Disorders of Sex Development (DSD) Center and the assistant director of the pediatric endocrinology fellowship training program.

Dr. Rutter cares for children and adolescents with a wide spectrum of endocrine conditions, including growth, puberty, thyroid and adrenal disorders. She collaborates with interdisciplinary specialists to deliver the endocrine aspects of comprehensive and integrated care for patients with complex conditions. She leads the Cincinnati Children’s DSD Center, which provides interdisciplinary care for people born with conditions affecting reproductive development. The DSD Center is a member of the DSD-Translational Research Network, a national network that strives to optimize and standardize clinical practices and advance scientific knowledge in this field. Dr. Rutter also serves as the primary endocrine consultant for the Cincinnati Comprehensive Neuromuscular Center. In conjunction with the neuromuscular team, she has helped pioneer global awareness of the importance of endocrine issues in patients affected by Duchenne Muscular Dystrophy.

MB, BCh: University of Wales College of Medicine, Cardiff, United Kingdom.

FRACP: Royal Australasian College of Physicians, New Zealand.

Residency: University Hospital of Wales, Cardiff, United Kingdom; Auckland Children's Hospital, Auckland, and Dunedin Hospital, Dunedin, New Zealand; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Certification: American Subspecialty Board of Pediatric Endocrinology, 2003, recertified 2013; American Board of Pediatrics, 2002; Fellow of the Royal Australasian College of Physicians (Pediatrics), 1995.

View PubMed Publications

Sawnani H, Horn PS, Wong BL, Darmahkasih A, Rybalsky I, Shellenbarger KC, Tian C, Rutter MM, Simakajornboon N, Amin R, Gurbani N, Pascoe J, Burrows C, Khirani S, Amaddeo A, Fauroux B. Comparison of pulmonary function decline in steroid-treated and steroid-naïve patients with Duchenne Muscular Dystrophy. J Pediatr. 2019.

Ernst MM, Gardner M, Mara CA, Délot EC, Fechner PY, Fox M, Rutter MM, Speiser PW, Vilain E, Weidler EM, Sandberg DE. Psychosocial screening in Disorders/Differences of Sex Development (DSD): Psychometric evaluation of the Psychosocial Assessment Tool. Horm Res Paediatr. 2019.

Kranenburg LJC, Reerds STH, Cools M, Alderson J, Muscarella M, Magrite E, Kuiper M, Abdelgaffar S, Balsamo A, Brauner R, Chanoine JP, Deeb A, Fechner P, German A, Holterhus PM, Juul A, Mendonca BB, Neville K, Nordenstrom A, Oostdijk W, Rey RA, Rutter MM, Shah N, Luo X, Grijpink K, Drop SLS. Global application of the assessment of communication skills of paediatric endocrinology fellows in the management of differences of sex development using the ESPE portal. Horm Res Paediatr. 2017;88(2):127-139.

Wasserman HM, Hornung LN, Stenger PJ, Rutter MM, Wong BL, Rybalsky I, Khoury J, Kalkwarf HJ. Low bone mineral density and fractures are highly prevalent in pediatric patients with Spinal Muscular Atrophy regardless of disease severity. Neuromuscul Disord. 2017 Apr;27(4):331-337.

Wong BL, Rybalsky I, Shellenbarger KC, Tian C, McMahon MA, Rutter MM, Sawnani H, Jefferies JL. Long term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment. J Pediatr. 2017 Mar;182:296-303.e1.

Tian C, Wong BL, Hornung L, Khoury JC, Miller L, Bange J, Rybalsky I, Rutter MM. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2016 Nov;26(11):760-767.

Rutter MM, Jha P, Schultz KAP, Sheil A, Harris AK, Bauer AJ, Field AL, Geller J, Hill DA. DICER1 mutation and differentiated thyroid carcinoma: Evidence of a direct association. J Clin Endocrinol Metab. 2016 Jan;101(1):1-5.

Chuang J, Vallerie A, Breech L, Saal HM, Alam S, Crawford P, Rutter MM. Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy? International Journal of Pediatric Endocrinology. 2013 Sep 12;2013(1):15.

Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, Hor KN, Cripe LH, Wong BL. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscul Disord. 2012;22(12):1046-1056. 

Bianchi ML, Biggar D, Bushby K, Rogol AD, Rutter MM, Tseng B. Endocrine aspects of Duchenne Muscular Dystrophy. Neuromuscul Disord. 2011 Apr;21(4):298-303.

Disorders / Differences of Sex Development (DSD)-Translational Research Network. Co-investigator (principal investigator for the Cincinnati site). National Institutes of Health / National Institute of Child Health and Human Development. Jul 2018-Mar 2023. R01 HD093450-01A1.

Decision-making for patients born with differences of sex development (DSD): Defining successful outcomes and trade-offs in DSD. Co-investigator (principal investigator for the Cincinnati site). National Institutes of Health / National Institute of Child Health and Human Development. Sep 2016-Jun 2021. R01 HD086583-01A1.